<DOC>
	<DOCNO>NCT02047058</DOCNO>
	<brief_summary>The purpose study determine whether Q cell separate glioma sample determinant treatment response prognosis glioma patient</brief_summary>
	<brief_title>Treatment Response Prognosis Glioma Patients : Q Cell Its Biological Characteristics</brief_title>
	<detailed_description>The unique marker Qcell screen use method genomics proteomics , marker qualitatively quantitatively evaluated glioblastoma patient compare relationship overrall survival/progression-free survival treatment response .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<criteria>1 . &gt; =18 year old 2 . Primary Glioblastoma newly diagnose confirm histologically 3 . Patient expect treated temozolomide follow routinely study site . 4 . Willing sign inform consent 1 . Currently enrol clinical study 2 . History malignancies 3 . Refusal give consent 4 . No available tumor tissue IDH analysis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>biomarker</keyword>
	<keyword>Q cell</keyword>
	<keyword>Overall survival</keyword>
	<keyword>Progression-free survival</keyword>
</DOC>